CEVEC is a global solution provider focussing on the development of top notch human expression systems with highest ethical standards. Our platform expression technologies CAP and CAP-T are based on specific, amniocyte derived human cell lines.
CAP and CAP-T are designed for stable and transient protein production and achieve highest protein yields with authentic human glycosylation patterns.
We have a high focus on research and development, production and marketing of our cell systems for protein and vaccine production accompanied by our development of selected “bio-better” and “bio-superior” candidates.
|07/01/11||Series B||8.6M||NRW Bank, Creathor Venture Funds||Unknown|